Loading viewer...
investor_presentation
Format: PDF investor_presentation
Lonza Group Ltd announced the acquisition of Capsugel to accelerate growth across the healthcare continuum. The deal, presented in December 2016, combines Lonza's pharmaceutical and biotech capabilities with Capsugel's capsule and dosage form technologies. This strategic acquisition strengthens Lonza's position as an integrated supplier across pharmaceutical manufacturing and life sciences sectors.
investor_presentation
34 Pages
Sasol
Nova Eye Medical FY21 H1 Investor Presentation
investor_presentationinvestor_presentation
19 Pages
Nova Eye Medical Limited
investor_presentation
Severn Trent